Martini started helping people in 2004 after Hurricane Charley hit Florida. But more than 20 years later, what began as ...

MoonLake’s stock rocketed 20% after reports claimed Merck made a $3 billion acquisition offer to boost its drug pipeline.

Stocks closed higher on Tuesday as the Nasdaq Composite finished the day higher for the year even as uncertainty over global ...

Biotech stock MoonLake Immunotherapeutics rocketed Tuesday on a report Merck offered to buy it for "more than $3 billion." ...

Barreling toward the loss of exclusivity on its blockbuster oncology therapy Keytruda, Merck & Co. has reportedly offered $3 ...

Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it ...

Merck recently made a nonbinding offer to acquire Swiss biotech firm MoonLake for over $3 billion, seeking to boost its drug ...

Merck & Co., Inc. (NYSE: MRK) has explored a potential acquisition of Swiss biotech firm MoonLake Immunotherapeutics in a ...

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

North Branch Land Trust is inviting nature lovers, conservationists and families to attend their Paddle and Pour event at 11 ...

Duck Dynasty's' Phil Robertson, who is suffering with Alzheimer's disease, harvested his first ducks as an 11-year-old boy ...

MoonLake Immunotherapeutics (NASDAQ:MLTX), a biopharmaceutical company focused on developing treatments for various diseases, finds itself at a crucial juncture in its growth trajectory. With a clear ...